Last reviewed · How we verify
Tolseram (mephenesin carbamate)
Tolseram (generic name: mephenesin carbamate) is a drug. It is currently in unknown development.
Tolseram works by modulating the activity of certain neurotransmitters in the brain.
Tolseram (mephenesin carbamate) is a small molecule modality with unknown drug class and target. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. Tolseram is used to treat unknown indications, and its key safety considerations are also unknown. Further research is needed to understand its pharmacology and clinical applications. As a result, it is not possible to provide a comprehensive summary of this medication.
At a glance
| Generic name | mephenesin carbamate |
|---|---|
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Think of it like a volume control for your brain's signals. Tolseram helps to adjust the level of certain chemical messengers, or neurotransmitters, that allow different parts of the brain to communicate with each other. This can help to regulate various bodily functions and behaviors.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tolseram CI brief — competitive landscape report
- Tolseram updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Tolseram
What is Tolseram?
How does Tolseram work?
What is the generic name of Tolseram?
What development phase is Tolseram in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing